NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Carcinoma



New carcinoma study findings have been reported by C. Saldana and co-researchers



April 9th, 2009

"Breast carcinoma-derived MCF-7 cells are frequently used in biomedical research. However, few reports exist regarding the characterization of signaling mechanisms in these cancerous cells involved in intracellular Ca2+ dynamics," scientists writing in the journal Molecular and Cellular Biochemistry report.

"Consequently, the aim of these experiments was to characterize the ryanodine receptor/Ca2+ release channel (RyR) present in MCF-7 cells. Ryanodine (100 nM), cADPR (5 mc M), and caffeine (10 mM) promoted cytoplasmic Ca2+ mobilization; in contrast, ryanodine at inhibitory concentration (100 mc M) decreased the basal Ca2+ level. Fluorescent probes demonstrated...


Source: Women's Health Weekly (2009-04-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login